The BRIC CGM market witnessed strong growth in recent decades and is further expected to grow thanks to the increasing adaptation of continuous glucose monitoring devices in China and India primarily. This rising diabetic population in Brazil, Russia, India, and China and increasing the adoption of CGM devices and Continuous Positive Cost-Effective Analysis by BRIC Countries will propel the expansion of the BRIC CGM market. China has the biggest market share in 2019; while, India is foreseen to witness a major market share during the forecast period. Consistent with Renub Research analysis, the BRIC CGM Market will reach US$ 868 Million by the top of the year 2025.
As the name suggests, SMBG stands for Self Monitoring of blood glucose device, used for self sugar level monitoring for diabetic patients at home. It helps diabetic patients to create a diet plan, reduce anxiety and inform doctor also as patients that how good their medication is working. Type 1 diabetic patients require daily monitoring of their glucose level—the frequency of blood glucose monitoring from diabetes type. Type 1 diabetic patients need multiple time monitoring during a single day.
‘BRIC Self-Monitoring blood glucose Device Market, Users, SMBG Components (Test Strips, Lancet, Meter) & Forecast’ studies the BRIC Countries blood glucose Device Segments Market: glucose Test Strips Market, blood glucose Lancet Market, and blood glucose Meter Market. The yearly forecast is provided from 2018 through 2024. A Seven-year historic analysis is additionally provided for these markets. This marketing research report provides a complete analysis of all four countries Brazil, Russia, India & China, Self-Monitoring blood glucose (SMBG) Market.
Diabetes could be a clinical condition where the inability of the pancreas to supply insulin causes the glucose level within the body to increase. The factors accountable for the increasing incidence of diabetes is the lack of physical activity, the harmful use of alcohol, tobacco consumption, and obesity. The key factor driving the market growth is the increasing geriatric population susceptible to various chronic diseases. Consistent with the United Nation statistics, the quantity of BRIC population older than 65 years is predicted to succeed in 295 million by 2020 and 412 million by 2030.
Increasing healthcare expenditure is additionally anticipated to fuel the market for diabetes care devices within the BRIC nations. for example, Brazil’s healthcare spending per GDP is anticipated to increase from 8.3% in 2014 to 10.0% in 2030. Several Gov. initiatives and products launches within the field of diabetes care are expected to propel market growth. For example, in 2019, Research Trust of Diabetes India launched its 1000 days Initiative to manage diabetes within the country. This initiative is predicted to bring diabetologists across the country to supply recommendations and clinical guidelines.
Trusted Business Insights presents an updated and Latest Study on BRIC Diabetes Care Devices Market 2019-2026. While emphasizing the key driving and restraining forces for this market, the report also offers a whole study of the longer-term trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects, including the socio-political landscape that’s anticipated to shape the demand of the BRIC Diabetes Care Devices market during the forecast period (2019-2029). It also examines the role of the leading market players involved within the industry, including their corporate overview, financial summary, and SWOT analysis.
The BRIC CGM market is driven mainly by the increasing numbers of people with diabetes across BRIC countries, growing diabetes research, and increasing international research collaborations. The continual Positive Cost-Effective Analysis by BRICS Countries and rapid urbanization and CGM Technology Convenient for both Patients & Physicians are further expected to contribute to the expansion of this CGM market. However, Controversy regarding Clinical Benefits and therefore, the high cost of diabetes care devices are the remonstrance growth of this market.
In the year Feb 2019, Senseonics made a contract with Roche Diabetes look after two years, giving exclusive rights to the large Biotech for selling implantable glucose monitoring systems in Brazil, Russia, India, and China. The continual glucose monitoring (CGM) devices market in BRIC countries are set to thrive no matter the main upheaval caused by the COVID-19 pandemic. The surging demand for CGM in BRIC countries is primarily driven by a growing awareness of the devices and companies’ quick responses to the COVID-19 epidemic.
Renub Research latest study “BRIC CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the BRIC CGM Market.
• CGM Market
• CGM Users
• CGM Reimbursements Policy
Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=bric-cgm-market-p.php
Scope of the Report
- CGM Market & Forecast: In this report, we have fragmented the CGM market into two parts; CGM transmitter market and CGM Sensor Market. We have cover 4 countries along with growth factors.
- CGM Users & Forecast: We have computed CGM user of top 4 countries. Historical data is computed from 2011-2019, and forecast data would be shown from 2020-2025.
- Reimbursement Policy: This report provides a changing picture of Reimbursement Policy on CGM (Continuous Glucose Monitoring) BRIC and country wise. Reimbursement model of BRIC that will give the overall situation of CGM acceptance across private and public hospitals and insurer.
- Diabetes Population: Report covers population & forecast of 4 (Type 1 and Type 2 diabetes)
- Growth Factors for CGM: This report studies the key factor that would help the CGM industry to outperform.
- Challenges for CGM: This industry shows the problems being faced by the CGM technology and industry.
Countries Covered
1. Brazil
2. Russia
3. India
4. China
About Company:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research
0 Comments